logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9006449 B1

PDFFull Text
Date of Patent:
Apr. 14, 2015

Filed:

Jul. 27, 2011

Cyclopropylamine derivatives useful as lsd1 inhibitors

Applicants:

Matthew Colin Thor Fyfe, Chipping Norton, GB;

Alberto Ortega Muñoz, Barcelona, ES;

Julio Castro-palomino Laria, Premiá de Mar, ES;

Marc Martinell Pedemonte, Barcelona, ES;

Maria DE Los Ángeles Estiarte-martinez, Barcelona, ES;

Nuria Valls Vidal, Barcelona, ES;

Inventors:

Matthew Colin Thor Fyfe, Chipping Norton, GB;

Alberto Ortega Muñoz, Barcelona, ES;

Julio Castro-Palomino Laria, Premiá de Mar, ES;

Marc Martinell Pedemonte, Barcelona, ES;

Maria de los Ángeles Estiarte-Martinez, Barcelona, ES;

Nuria Valls Vidal, Barcelona, ES;

Assignee:

Oryzon Genomics, S.A., Barcelona, ES;

Attorney:

Finnegan, Henderson, Farabow, Garrett & Dunner

Primary Examiner:

John Mabry

Int. Cl.
CPC ...
C07D 401/00 (2006.01); C07D 277/28 (2006.01); A61K 31/44 (2006.01); C07C 211/40 (2006.01); C07C 215/64 (2006.01); C07C 217/74 (2006.01); C07C 255/53 (2006.01); C07C 255/54 (2006.01); C07C 311/08 (2006.01); C07C 311/09 (2006.01); C07C 311/21 (2006.01); C07D 213/38 (2006.01); C07D 213/40 (2006.01); C07D 213/42 (2006.01); C07D 213/56 (2006.01); C07D 213/57 (2006.01); C07D 239/26 (2006.01); C07D 333/20 (2006.01); C07D 401/04 (2006.01); C07D 405/04 (2006.01); C07D 409/04 (2006.01); C07C 255/59 (2006.01); C07D 213/64 (2006.01); C07D 401/10 (2006.01); C07D 405/10 (2006.01); C07D 409/10 (2006.01);
U.S. Cl.
CPC ...
C07C 211/40 (2013.01); C07C 215/64 (2013.01); C07C 217/74 (2013.01); C07C 255/53 (2013.01); C07C 255/54 (2013.01); C07C 311/08 (2013.01); C07C 311/09 (2013.01); C07C 311/21 (2013.01); C07D 213/38 (2013.01); C07D 213/40 (2013.01); C07D 213/42 (2013.01); C07D 213/56 (2013.01); C07D 213/57 (2013.01); C07D 239/26 (2013.01); C07D 277/28 (2013.01); C07D 333/20 (2013.01); C07D 401/04 (2013.01); C07D 405/04 (2013.01); C07D 409/04 (2013.01); C07C 255/59 (2013.01); C07D 213/64 (2013.01); C07D 401/10 (2013.01); C07D 405/10 (2013.01); C07D 409/10 (2013.01); C07B 2200/07 (2013.01); C07C 2101/02 (2013.01);
Abstract

The invention relates to cyclopropylamine compounds, in particular the compounds of Formula (I), and their use in therapy, including e.g. in the treatment or prevention of cancer, a neurological disease or condition, or viral infection.

Find Patent Forward Citations

Loading…